Singapore markets closed

VRTX Sep 2022 165.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
84.600.00 (0.00%)
As of 10:32AM EDT. Market open.
Full screen
Previous close84.60
Open84.60
Bid122.10
Ask129.50
Strike165.00
Expiry date2022-09-16
Day's range84.60 - 84.60
Contract rangeN/A
Volume2
Open interest3
  • Zacks

    CRISPR Therapeutics (CRSP) Q2 Earnings & Sales Miss Estimates

    CRISPR Therapeutics (CRSP) reports a wider-than-expected Q2 loss. Revenues also miss estimates.

  • Motley Fool

    2 Top Biotech Stocks Defying the Bear Market

    Vertex Pharmaceuticals' shares have soared 24% year to date despite the macroeconomic headwinds in its way. The biotech owes that in part to its dominance in the market for drugs that treat the underlying causes of cystic fibrosis (CF), an area in which Vertex is the only game in town. Revenue and earnings continue to grow for Vertex thanks to its CF franchise.

  • Motley Fool

    Why Vertex Pharmaceuticals Stock Was Soaring Today

    An estimates-beating quarter and raised guidance were the elements pushing Vertex Pharmaceuticals (NASDAQ: VRTX) shares comfortably higher on Friday. After market hours on Thursday, Vertex published its second-quarter results. Vertex's growth was powered by its current blockbuster drug, Trikafta.